BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Merrimack Pharmaceuticals Inc. 

101 Binney Street

Cambridge  Massachusetts  02142  U.S.A.
Phone: 617-441-1000 Fax: 617-491-1386


SEARCH JOBS



Segment
Start Up

Collaborations

Dyax Corp.  Antibody phage display





 Company News
Merrimack Pharmaceuticals Inc. (MACK) Announces Preliminary Data From Pilot Diagnostic Imaging Study Of MM-398 4/8/2014 7:32:41 AM    More...
Merrimack Pharmaceuticals Inc. (MACK) To Present At The 2014 American Association for Cancer Research Annual Meeting 3/31/2014 9:25:57 AM    More...
Merrimack Pharmaceuticals Inc. (MACK) Provides Fourth Quarter And Full Year 2013 Financial Result 2/28/2014 9:43:17 AM    More...
Merrimack Pharmaceuticals Inc. (MACK) To Present At The Cowen And Company 34th Annual Health Care Conference 2/24/2014 8:44:46 AM    More...
Merrimack Pharmaceuticals Inc. (MACK) Announces Timing Of Fourth Quarter 2013 Investor Conference Call 2/21/2014 8:50:08 AM    More...
Preclinical Study Results Of Merrimack Pharmaceuticals Inc. (MACK)'s MM-141 Published In Molecular Cancer Therapeutics 2/18/2014 9:02:52 AM    More...
Merrimack Pharmaceuticals Inc. (MACK) Initiates Phase 1 Clinical Study Of MM-398 In Combination With Cyclophosphamide For Pediatric Solid Tumors 1/23/2014 9:37:34 AM    More...
Merrimack Pharmaceuticals Inc. (MACK) To Present Preclinical Data At The American Society of Clinical Oncology 2014 Gastrointestinal Cancers Symposium 1/13/2014 9:37:44 AM    More...
Merrimack Pharmaceuticals Inc. (MACK) To Present At The 32nd Annual J.P. Morgan Healthcare Conference 12/20/2013 9:33:57 AM    More...
Merrimack Pharmaceuticals Inc. (MACK) Announces Encouraging Clinical Data From Expanded Phase 1 Study Of MM-302 For The Treatment Of Advanced HER2-Positive Breast Cancer 12/13/2013 9:28:45 AM    More...
12345678910...

//-->